New chairman to prepare Leo Pharma for IPO with new launches and financial discipline
Leo Pharma's incoming chairman Jesper Brandgaard says that the company might get listed at some point in the future. Firstly, however, new products must be launched, and the company's earning capacity needs to be improved, according to the former CFO, who operates with a 3-5 year time frame.
BY ANDREAS LØNSTRUP, TRANSLATED BY NIELSINE NIELSEN
2021 has been a busy year for Leo Pharma.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ferring appoints Lars Rebien Sørensen as new chairman
For subscribers
US dermatology top boss moves to Danish biotech firm
For subscribers
